Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair.

Seeger FH, Rasper T, Fischer A, Muhly-Reinholz M, Hergenreider E, Leistner DM, Sommer K, Manavski Y, Henschler R, Chavakis E, Assmus B, Zeiher AM, Dimmeler S.

Circ Res. 2012 Sep 14;111(7):854-62. doi: 10.1161/CIRCRESAHA.112.265678. Epub 2012 Jul 19.

2.

Heparin and bone marrow-derived cell therapy: friend or foe?

Yeh ET, Willerson JT.

Circ Res. 2012 Sep 14;111(7):819-20. doi: 10.1161/CIRCRESAHA.112.277517. No abstract available.

3.

CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.

Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S.

Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1802-9. doi: 10.1161/ATVBAHA.109.194688. Epub 2009 Aug 20.

4.

Sustained-release delivery of prostacyclin analogue enhances bone marrow-cell recruitment and yields functional benefits for acute myocardial infarction in mice.

Imanishi Y, Miyagawa S, Fukushima S, Ishimaru K, Sougawa N, Saito A, Sakai Y, Sawa Y.

PLoS One. 2013 Jul 19;8(7):e69302. doi: 10.1371/journal.pone.0069302. Print 2013.

5.

A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.

Cheng M, Huang K, Zhou J, Yan D, Tang YL, Zhao TC, Miller RJ, Kishore R, Losordo DW, Qin G.

J Mol Cell Cardiol. 2015 Apr;81:49-53. doi: 10.1016/j.yjmcc.2015.01.024. Epub 2015 Feb 3.

6.
7.

Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis.

Brunner S, Winogradow J, Huber BC, Zaruba MM, Fischer R, David R, Assmann G, Herbach N, Wanke R, Mueller-Hoecker J, Franz WM.

FASEB J. 2009 Feb;23(2):351-61. doi: 10.1096/fj.08-109462. Epub 2008 Sep 30.

PMID:
18827024
8.

Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.

Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C, Spyridopoulos I, Chun J, Brinkmann V, Keul P, Levkau B, Zeiher AM, Dimmeler S, Haendeler J.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):275-82. Epub 2006 Dec 7.

9.

Effect of TGF-β1/SDF-1/CXCR4 signal on BM-MSCs homing in rat heart of ischemia/perfusion injury.

Zhang SJ, Song XY, He M, Yu SB.

Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):899-905.

10.

CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1alpha/CXCR4 signaling axis.

Li M, Yu J, Li Y, Li D, Yan D, Qu Z, Ruan Q.

Exp Mol Pathol. 2010 Apr;88(2):250-5. doi: 10.1016/j.yexmp.2009.12.001. Epub 2009 Dec 16.

PMID:
20025867
11.

The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice.

Ziegler M, Elvers M, Baumer Y, Leder C, Ochmann C, Schönberger T, Jürgens T, Geisler T, Schlosshauer B, Lunov O, Engelhardt S, Simmet T, Gawaz M.

Circulation. 2012 Feb 7;125(5):685-96. doi: 10.1161/CIRCULATIONAHA.111.070508. Epub 2012 Jan 5.

12.
13.

Endothelial NOS is required for SDF-1alpha/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells.

Kaminski A, Ma N, Donndorf P, Lindenblatt N, Feldmeier G, Ong LL, Furlani D, Skrabal CA, Liebold A, Vollmar B, Steinhoff G.

Lab Invest. 2008 Jan;88(1):58-69. Epub 2007 Nov 26.

14.

SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury.

Huang C, Gu H, Zhang W, Manukyan MC, Shou W, Wang M.

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1496-505. doi: 10.1152/ajpheart.00365.2011. Epub 2011 Aug 5.

15.

Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.

Shiba Y, Takahashi M, Hata T, Murayama H, Morimoto H, Ise H, Nagasawa T, Ikeda U.

Cardiovasc Res. 2009 Jan 1;81(1):169-77. doi: 10.1093/cvr/cvn247. Epub 2008 Sep 12.

PMID:
18791205
16.

Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4(+) stem cells into the ischaemic heart.

Huber BC, Brunner S, Segeth A, Nathan P, Fischer R, Zaruba MM, Vallaster M, Theiss HD, David R, Gerbitz A, Franz WM.

Cardiovasc Res. 2011 Jun 1;90(3):529-37. doi: 10.1093/cvr/cvr014. Epub 2011 Jan 18.

PMID:
21245057
17.

Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.

Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T.

Arthritis Rheum. 2009 Mar;60(3):813-23. doi: 10.1002/art.24330.

18.

Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.

Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino F, Piacibello W, Aglietta M.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):490-7.

19.

Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.

Plett PA, Frankovitz SM, Wolber FM, Abonour R, Orschell-Traycoff CM.

Exp Hematol. 2002 Sep;30(9):1061-9.

PMID:
12225798
20.

CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.

Cheng M, Zhou J, Wu M, Boriboun C, Thorne T, Liu T, Xiang Z, Zeng Q, Tanaka T, Tang YL, Kishore R, Tomasson MH, Miller RJ, Losordo DW, Qin G.

Circ Res. 2010 Oct 29;107(9):1083-93. doi: 10.1161/CIRCRESAHA.110.220970. Epub 2010 Sep 16.

Supplemental Content

Support Center